New biorepository aims to unlock secrets of lipedema

NCT ID NCT06180850

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This completed study created a biorepository of blood and tissue samples from 60 women with and without lipedema. The goal was to find molecular markers that can distinguish lipedema from obesity, which is often misdiagnosed. Researchers measured immune markers and physical function tests to better understand the disease.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this could lead to better diagnostic tools for lipedema, helping distinguish it from obesity and enabling earlier management.

What could go wrong

This is an observational study that does not test a treatment, so it will not directly help patients. Results may not lead to immediate clinical changes.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LIPEDEMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Lipedema

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Vanderbilt University Medical Center

    Nashville, Tennessee, 37203, United States